PharmaCyte Biotech, Inc. (PMCB) Financials
PMCB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-10-31 | 78.9 million | 20.8 million |
2023-07-31 | 79.9 million | 20.4 million |
2023-04-30 | 73.3 million | 586581 |
2023-01-31 | 78.0 million | 827834 |
PMCB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-10-31 | -2.0 million | ? |
2023-07-31 | 342959 | ? |
2023-04-30 | -288388 | -638072 |
2023-01-31 | -541701 | 629932 |
PMCB Net Income
No data available :(
PMCB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-10-31 | 73.4 million | - | - |
2023-07-31 | 74.7 million | - | - |
2023-04-30 | 68.0 million | - | - |
2023-01-31 | 72.6 million | - | - |
PMCB Shares Outstanding
PMCB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-10-31 | - | 82033 | 1.1 million | - |
2023-07-31 | - | 104483 | 1.7 million | - |
2023-04-30 | - | 85874 | 817409 | - |
2023-01-31 | - | 45393 | 1.5 million | - |
PMCB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-10-31 | - | - |
2023-07-31 | - | - |
2023-04-30 | - | - |
2023-01-31 | - | - |
PMCB
Price: $2.11
52 week price:
Earnings Per Share: -1.48 USD
P/E Ratio: -2.48
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 64200
Market Capitalization: 19.1 million